Breast cancerImmunohistochemistryMarkersThe biological characteristics of the tumour are used to estimate prognosis and select appropriate systemic therapy for patients with(breast)cancer.The advent of molecular technology has incorporated new biomarkers along with immunohistochemical and serum biomarkers.Immunohisto...
Cancer types: Colorectal cancer and breast cancer Tissue analyzed: Blood How used: To check whether colorectal cancer has spread; to look for breast cancer recurrence and assess response to treatment CD20 Cancer type: Non-Hodgkin lymphoma
PATIENTS AND METHODS: A study included 150 patients with breast cancer attending Baghdad oncology teaching hospital between June 2019 and December 2019 (50 cases with negative recurrence history and 100 recurrence cases) for whom data including age, stage, grade, histopathological type, ...
Immunohistochemistry and Multigene Assays in Breast CancerMiller, Dylan V
Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are tumor markers for breast cancer and are recommended for use on all primary breast cancers and, more recently, on metastatic breast cancer. They are critical tumor markers for breast cancer...
Triple‐negative breast cancerMolecular classificationImmunohistochemistryPrecision medicineBACKGROUND. Molecular subtyping of triple‐negative breast cancers (TNBCs) via gene expression profiling is essential for understanding the molecular essence of this heterogeneous disease and for guiding individualized ...
113PImportance of immunohistochemistry for quick selection of breast cancer patients having BRCA1/2 mutations for their better treatment strategy: Pilot study in eastern IndiaPurify and structural determination of protein complexes isolated from mammalian cells....
immunohistochemistryUsing array analysis for screening RNA from BRCA1-mutated and sporadic breast tumors, we observed that AIGF/FGF-8 expression was lost in... EMJJ Berns,MJM Dirkzwager-Kiel,V Kuenen-Boumeester,... - 《Breast Cancer Research & Treatment》 被引量: 98发表: 2003年 BRCA1 Gene...
Although successful in reducing the mortality of breast cancer patients, this approach does not allow for the individualisation of the therapy for breast cancer patients. High throughput molecular data on the different subtypes of breast cancer have led to the identification of new prognostic and ...
Immunohistochemistry and histopathology study of breast cancer patients in Al-Najaf Governorate 来自 Semantic Scholar 喜欢 0 阅读量: 6 作者:D Musa,N Mezher,M Khalfa,AH Abood 摘要: This work was directed to get a comparison between the conventional methods ELISA commonly used in lab study for ...